Inventor · disambiguated record
Paul K. Isbester
Also filed as: ISBESTER PAUL · ISBESTER PAUL K · ISBESTER PAUL KENNETH
26 granted patents·11 pending applications·239 citations·filing 2004–2024
97Inventor score
Files withINFINITY PHARMACEUTICALS INC7TAKEDA PHARMACEUTICAL6FENG JUN5ATHENEX INC4HANGAUER JR DAVID G3
Top patents by PatentIndex Score
37 records- 0195US7935697B2Compositions for modulating a kinase cascade and methods of use thereofKINEX PHARMACEUTICALS LLC·Filed 2009·Granted May 3, 2011·29 cites·13 claims
- 0294US8309549B2Compositions for modulating a kinase cascade and methods of use thereofHANGAUER JR DAVID G·Filed 2011·Granted Nov 13, 2012·19 cites·19 claims
- 0394US7939529B2Process for the preparation of compositions for modulating a kinase cascade and methods of use thereofKINEX PHARMACEUTICALS LLC·Filed 2008·Granted May 10, 2011·33 cites·11 claims
- 0494US7781584B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2007·Granted Aug 24, 2010·17 cites·4 claims
- 0593US8901297B2Compositions for modulating a kinase cascade and methods of use thereofHANGAUER JR DAVID G·Filed 2012·Granted Dec 2, 2014·14 cites·10 claims
- 0693US8809349B2Processes for preparing isoquinolinones and solid forms of isoquinolinonesREN PINGDA·Filed 2012·Granted Aug 19, 2014·26 cites·65 claims
- 0793US7807689B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2005·Granted Oct 5, 2010·16 cites·51 claims
- 0891US8293739B2Process for the preparation of compositions for modulating a kinase cascade and methods of use thereofHANGAUER JR DAVID G·Filed 2011·Granted Oct 23, 2012·17 cites·11 claims
- 0990US7795428B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2007·Granted Sep 14, 2010·12 cites·59 claims
- 1089US10323001B2Compositions for modulating a kinase cascade and methods of use thereofATHENEX INC·Filed 2016·Granted Jun 18, 2019·5 cites·1 claims
- 1189US9556120B2Compositions for modulating a kinase cascade and methods of use thereofATHENEX INC·Filed 2014·Granted Jan 31, 2017·7 cites·12 claims
- 1289US9340565B2Crystalline formsHANNA MAZEN·Filed 2011·Granted May 17, 2016·5 cites·20 claims
- 1386US9290497B2Processes for preparing isoquinolinones and solid forms of isoquinolinonesINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Mar 22, 2016·6 cites·37 claims
- 1486US8288539B2Dipeptidyl peptidase inhibitorsFENG JUN·Filed 2007·Granted Oct 16, 2012·6 cites·31 claims
- 1586US2025197400A1Processes for preparing isoquinolinones and solid forms of isoquinolinonesINFINITY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1685US8188275B2Dipeptidyl peptidase inhibitorsFENG JUN·Filed 2007·Granted May 29, 2012·4 cites·4 claims
- 1785US8173663B2Dipeptidyl peptidase inhibitorsFENG JUN·Filed 2007·Granted May 8, 2012·5 cites·29 claims
- 1885US7906523B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2007·Granted Mar 15, 2011·4 cites·15 claims
- 1983US11312718B2Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-oneINFINITY PHARMACEUTICALS INC·Filed 2020·Granted Apr 26, 2022·1 cites·34 claims
- 2082US8222411B2Dipeptidyl peptidase inhibitorsFENG JUN·Filed 2006·Granted Jul 17, 2012·8 cites·5 claims
- 2177US7812050B2Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxideCENERX BIOPHARMA INC·Filed 2007·Granted Oct 12, 2010·5 cites·17 claims
- 2277US2023108157A1Formulations of (s)-3-(1-(9h-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2h)-oneINFINITY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2368US2024343691A1Compositions for modulating a kinase cascade and methods of use thereofATNX SPV LLC·Filed 2023·Application pending·0 cites
- 2467US10550122B2Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Feb 4, 2020·0 cites·31 claims
- 2567US2019256468A1Compositions for modulating a kinase cascade and methods of use thereofATHENEX INC·Filed 2019·Application pending·0 cites
- 2666US10519176B2Crystalline formsGRUENENTHAL CHEMIE·Filed 2017·Granted Dec 31, 2019·0 cites·15 claims
- 2765US8329900B2Dipeptidyl peptidase inhibitorsFENG JUN·Filed 2007·Granted Dec 11, 2012·0 cites·16 claims
- 2863US2021198202A1Compositions for modulating a kinase cascade and methods of use thereofATHENEX INC·Filed 2021·Application pending·0 cites
- 2962US9840505B2Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Dec 12, 2017·0 cites·31 claims
- 3061USRE46621EProcesses for preparing isoquinolinones and solid forms of isoquinolinonesINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Dec 5, 2017·0 cites·66 claims
- 3156US7928226B2Salts and polymorphs of a VEGF-R inhibitorAGOURON PHARMA·Filed 2006·Granted Apr 19, 2011·0 cites·4 claims
- 3256US2017022225A1Novel crystalline formsTHAR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3351US2011184178A1Polymorphs of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide and methods of use thereforTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 3451US2009270442A1Polymorphs of hydrochloride salt of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide and methods of use thereforTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 3548US2009187040A1Fenofibric acid polymorphs; methods of making; and methods of use thereofSUN TONG·Filed 2009·Application pending·0 cites
- 3644US2007293445A1Stable Elsamitrucin Salts Suitable for Pharmaceutical FormulationsSPECTRUM PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3734US2006047171A1Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifying and obtaining the polymorphs thereofMECKLER HAROLD·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →